December 21, 2020
“Lordstown Motors (RIDE)… Overall, RIDE shares get a Hold from the analyst consensus, reflecting Wall Street caution toward a new – and highly speculative – endeavor. The rating is derived from 4 recent reviews, evenly split between 2 Buys and 2… Continue Reading…
November 5, 2020
“Moderna (MRNA)… In general, other analysts are on the same page. 10 Buys, 1 Hold and 1 Sell add up to a Strong Buy consensus rating. With an average price target of $96.91, the upside potential comes in at ~37%…… Continue Reading…
November 2, 2020
“General Electric (GE)… Turning to the rest of the Street, opinions are split evenly. With 6 Buys and 6 Holds assigned in the last three months, the word on the Street is that GE is a Moderate Buy. At $8.20,… Continue Reading…
October 19, 2020
“Athira Pharma (ATHA)… Judging by the consensus breakdown, opinions are anything but mixed. With 4 Buys and no Holds or Sells assigned in the last three months, the word on the Street is that ATHA is a Strong Buy. At… Continue Reading…
September 22, 2020
“Intellia Therapeutics (NTLA)… Looking at the consensus breakdown, 3 Buys and 2 Holds have been published in the last three months. Therefore, NTLA gets a Moderate Buy consensus rating. Based on the $37.13 average price target, shares could rise 67%… Continue Reading…
September 9, 2020
“Rackspace Technology (RXT)… Goldman Sachs analyst Heather Bellini, rated 5 stars at TipRanks, rates RXT shares a Buy with a price target of $38, implying an impressive 99% upside potential for the stock this year… Plains All American Pipeline (PAA)… Overall, Plains… Continue Reading…
May 12, 2020
“ Goldman Sachs expects the S&P 500 to close the year 2% higher, but not before enduring an 18% plunge over the next three months. The stock market’s recent leap from late-March lows is best attributed to investors’ “fear of missing out,” the… Continue Reading…
April 27, 2020
“The narrowing group of winners in the S&P 500 doesn’t bode well for the future performance of U.S. stocks, according to Goldman Sachs Group Inc. The U.S. benchmark is around 17% below its February record, but the median stock trades… Continue Reading…
September 20, 2019
“Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (“Actinium”) today announced that it will present at the Sachs 19th Annual Biotech in Europe Forum for Global Partnering & Investment. The forum is being held at the Congress Center Basel in Basel, Switzerland on September 25-26, 2019.… Continue Reading…
Recent Comments